2015
DOI: 10.3389/fphys.2015.00066
|View full text |Cite
|
Sign up to set email alerts
|

Good and bad sides of TGFβ-signaling in myocardial infarction

Abstract: Myocardial infarction is a prevailing cause of death in industrial countries. In spite of the good opportunities we have nowadays in interventional cardiology to reopen the clotted coronary arteries for reperfusion of ischemic areas, post-infarct remodeling emerges and contributes to unfavorable structural conversion processes in the myocardium, finally resulting in heart failure. The growth factor TGFβ is upregulated during these processes. In this review, an overview on the functional role of TGFβ signaling … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
49
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(50 citation statements)
references
References 49 publications
1
49
0
Order By: Relevance
“…Although several Smad pathways have been reported, the canonical Smad pathway, including Smad2 and Smad3, is regarded as the primary pathway of TGF-b signaling. 38 As mentioned above, the mRNA expression levels of the TGF-b1 gene and downstream fibrosis-related genes during the remodeling phase were significantly lower in the MI+EPA group than in the MI+PBS group ( Figure 4A through 4C). To determine whether EPA treatment had an impact on TGF-b activity in vivo during the post-MI chronic phase, levels of Smad2 and Smad3, as transcription factors of the canonical Smad pathway, were determined by Western blotting.…”
Section: Tgf-b/smad Signaling Was Attenuated In the Epa-treated Mice mentioning
confidence: 55%
See 1 more Smart Citation
“…Although several Smad pathways have been reported, the canonical Smad pathway, including Smad2 and Smad3, is regarded as the primary pathway of TGF-b signaling. 38 As mentioned above, the mRNA expression levels of the TGF-b1 gene and downstream fibrosis-related genes during the remodeling phase were significantly lower in the MI+EPA group than in the MI+PBS group ( Figure 4A through 4C). To determine whether EPA treatment had an impact on TGF-b activity in vivo during the post-MI chronic phase, levels of Smad2 and Smad3, as transcription factors of the canonical Smad pathway, were determined by Western blotting.…”
Section: Tgf-b/smad Signaling Was Attenuated In the Epa-treated Mice mentioning
confidence: 55%
“…In the heart several cell types, including cardiomyocytes, endothelial cells, fibroblasts, and macrophages, release TGF-b1. 38 In addition, EPA prevented the upregulation of the protein and mRNA expression level of TGF-b1 in cultured cardiomyocytes after treatment with endothelin-1. 52 As a result, we believe that in our study, the altered TGF-b1 expression level 28 days after MI was not due to macrophages but, rather, to cardiomyocytes.…”
Section: Discussionmentioning
confidence: 98%
“…This mechanism is well-established in congestive heart failure, and ischemic heart disease. It is recognized as a predictor of adverse prognosis [11]. …”
Section: Introductionmentioning
confidence: 99%
“…TGF-␤ has been reported to play an important role in heart disease (33). TGF-␤ signaling is responsible for cardiomyocyte apoptosis and cardiac hypertrophy, and TGF-␤ also promotes myofibroblast formation and extracellular matrix (ECM) production, which leads to cardiac fibrosis (34)(35)(36). In addition, our lab has newly bought mice in which the CSIG gene has been conditionally knocked out from cardiac muscle.…”
Section: Discussionmentioning
confidence: 99%